Mechanisms of Immunosuppression in Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (30 December 2023) | Viewed by 21692
Special Issue Editor
Interests: immuno-oncology; macrophages; myeloid-derived suppressor cells; immunotherapy; immune-suppression in cancer; tumor microenvironment; solid tumors; metastasis
Special Issue Information
Dear Colleagues,
Cancer immunotherapy, including immune checkpoint blockade or adoptive cell therapy, has provided remarkable clinical benefit to some patients, while a significant fraction of patients get minimal or no benefit from this therapy. Tumor cells employ multiple mechanisms to evade immune responses, establishing an immunosuppressive tumor microenvironment that promotes resistance to immunotherapy.
Tumor-induced immunosuppression hampers and modulates the activity of cytotoxic T cells and NK cells through the secretion of various cytokines and metabolites, and recruitment of immunosuppressive cells such as myeloid-derived suppressor cells, tumor-associated macrophages, regulatory T cells, and regulatory B cells. Hence, it is crucial to understand various tumor-induced immunosuppressive mechanisms to design and develop effective novel immunotherapies and to refine approaches to improve currently available immunotherapies.
This Special Issue invites original research articles and review articles to address the mechanisms of tumor-induced immunosuppression, major impediments for effective antitumor immunity, and approaches to convert ‘cold tumors’ into ‘hot tumors’, which are focused on but not limited to the reprogramming of immune cells, novel immune checkpoints, normalizing tumor vasculature, cytokine modulation, metabolic intervention, targeting exosomes, and strategies to block the infiltration of immunosuppressive cells in the tumor bed.
Dr. Shweta Joshi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunosuppression
- immune cells
- tumor microenvironment
- immunotherapy
- immune checkpoint blockade
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.